Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

W Kruis,W Kruis,S Boehm,I A Gorelov,R Mueller,M Batovsky,S Boehm,G Kiudelis,R Greinwald,J Pokrotnieks,M Horynski,I Racz,J Kykal

doi:10.1136/gut.2008.154302

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

W Kruis, W Kruis + Show 11 more

Open Access

https://doi.org/10.1136/gut.2008.154302

Copy DOI

Journal: Gut	Publication Date: Oct 2, 2008
Citations: 188	License type: open-access

Affiliation: Evangelisches Krankenhaus Kalk, University of Cologne, Central Clinical Hospital and Polyclinic, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Dr Falk Pharma (Germany), Pauls Stradiņš Clinical University Hospital

#Once Daily #Three Times Daily Group + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Objectives:To determine the therapeutic equivalence and safety of once daily (OD) versus three times daily (TID) dosing of a total daily dose of 3 g Salofalk (mesalazine) granules in patients...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Gut

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.